The PE Ratio as of December 2024 (TTM) for Cyclo Therapeutics, Inc. (CYTH) is -0.67

According to Cyclo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.67. This represents a change of -55.83% compared to the average of -1.52 of the last 4 quarters.

Cyclo Therapeutics, Inc. (CYTH) Historical PE Ratio (quarterly & annually)

How has CYTH PE Ratio performed in the past?

The mean historical PE Ratio of Cyclo Therapeutics, Inc. over the last ten years is -10.44. The current -0.67 PE Ratio has changed 541.72% with respect to the historical average. Over the past ten years (40 quarters), CYTH's PE Ratio was at its highest in in the March 2022 quarter at 0.00. The PE Ratio was at its lowest in in the December 2014 quarter at -27.14.

Cyclo Therapeutics, Inc. (CYTH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cyclo Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclo Therapeutics, Inc. (CYTH) Average PE Ratio

How has CYTH PE Ratio performed in the past?

The current PE Ratio of Cyclo Therapeutics, Inc. (CYTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cyclo Therapeutics, Inc. (CYTH) PE Ratio vs. Peers

How is CYTH’s PE Ratio compared to its peers?

Cyclo Therapeutics, Inc.’s PE Ratio is less than Athenex, Inc. (-0.01), less than MedMen Enterprises Inc. (-0.00), less than Lifecore Biomedical, Inc. (35.59), greater than Lucy Scientific Discovery Inc. (-1.23), less than Guardion Health Sciences, Inc. (0.65), less than Agile Therapeutics, Inc. (-0.65), greater than Alpha Teknova, Inc. (-12.91), less than Petros Pharmaceuticals, Inc. (-0.26), less than Phibro Animal Health Corporation (49.59), greater than SOHM, Inc. (-3.29), less than Silver Spike Investment Corp. (0), less than Eagle Pharmaceuticals, Inc. (0.21), greater than Intra-Cellular Therapies, Inc. (-104.57), less than Ironwood Pharmaceuticals, Inc. (29.47), greater than Amneal Pharmaceuticals, Inc. (-13.13), greater than Aquestive Therapeutics, Inc. (-9.08), greater than Assertio Holdings, Inc. (-1.22), greater than AcelRx Pharmaceuticals, Inc. (-1.02),

Build a custom stock screener for Cyclo Therapeutics, Inc. (CYTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclo Therapeutics, Inc. (CYTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.